Search Ontology: 
        
        ChEBI
            N-[3-(aminomethyl)benzyl]acetamidine
- Term ID
 - CHEBI:90721
 - Synonyms
 - 
    
        
        
- 1400 W
 - 1400W
 - N-{[3-(aminomethyl)phenyl]methyl}ethanimidamide
 - W 1400
 - W1400
 
 - Definition
 - An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
 - References
 - 
    
        
        
    
    
- CAS:180001-34-7
 - Chemspider:1389
 - DrugBank:DB02044
 - PDBeChem:14W
 - PMID:11331003
 - PMID:11459438
 - PMID:11504810
 - PMID:11564663
 - PMID:12954642
 - PMID:20663293
 - PMID:24096697
 - PMID:24995119
 - PMID:25540738
 - PMID:25619924
 - PMID:26362773
 - PMID:26526764
 - PMID:27208748
 - PMID:27888018
 - PMID:29441689
 - PMID:29924417
 - PMID:30590117
 - PMID:30940499
 - PMID:31090233
 - PMID:31226744
 - PMID:32603502
 - PMID:33269785
 - PMID:9754916
 - Reaxys:8054187
 
 - Ontology
 - ChEBI ( EBI )
 
                
                    
                        Phenotype 
                    
                    
                
                
            
        
        
    
        
            
            
    
    
    
    
                
                    
                        Phenotype resulting from N-[3-(aminomethyl)benzyl]acetamidine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype where environments contain N-[3-(aminomethyl)benzyl]acetamidine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype modified by environments containing N-[3-(aminomethyl)benzyl]acetamidine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype affecting N-[3-(aminomethyl)benzyl]acetamidine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Human Disease Model